Zhejiang Xianju Pharmaceutical Co Ltd
SZSE:002332
Zhejiang Xianju Pharmaceutical Co Ltd
Net Income (Common)
Zhejiang Xianju Pharmaceutical Co Ltd
Net Income (Common) Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
Z
|
Zhejiang Xianju Pharmaceutical Co Ltd
SZSE:002332
|
Net Income (Common)
¥621.7m
|
CAGR 3-Years
1%
|
CAGR 5-Years
10%
|
CAGR 10-Years
30%
|
|
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Net Income (Common)
¥3.3B
|
CAGR 3-Years
8%
|
CAGR 5-Years
11%
|
CAGR 10-Years
N/A
|
|
|
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
|
Net Income (Common)
¥3.1B
|
CAGR 3-Years
9%
|
CAGR 5-Years
18%
|
CAGR 10-Years
23%
|
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Net Income (Common)
¥5.4B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
2%
|
CAGR 10-Years
14%
|
|
|
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
Net Income (Common)
¥4.3B
|
CAGR 3-Years
5%
|
CAGR 5-Years
3%
|
CAGR 10-Years
6%
|
|
|
C
|
CSPC Innovation Pharmaceutical Co Ltd
SZSE:300765
|
Net Income (Common)
¥311.4m
|
CAGR 3-Years
3%
|
CAGR 5-Years
3%
|
CAGR 10-Years
N/A
|
|
Zhejiang Xianju Pharmaceutical Co Ltd
Glance View
In the heart of eastern China, Zhejiang Xianju Pharmaceutical Co., Ltd. stands as a testament to China's evolving pharmaceutical prowess. Founded in 1972, Xianju Pharmaceutical has carved out a niche in the global healthcare market by specializing in the production of corticosteroids and hormone APIs (Active Pharmaceutical Ingredients). What sets Xianju apart is its relentless focus on research and development, enabling the company to produce a wide array of steroid and hormone products that cater to both domestic and international markets. The innovation pipeline is fueled by a robust R&D team that ensures the company remains at the forefront of pharmaceutical advancements, allowing it to consistently meet the stringent quality standards expected in this highly regulated industry. The company's financial engine runs on its ability to manufacture these high-demand products efficiently and at scale, leveraging advanced technologies and integrated production processes. This operational efficiency provides Xianju a competitive edge in price stability and market reach. The revenue stream is diversified yet strategically concentrated on its core competencies, allowing Xianju to capitalize on rising global demands for hormone therapies and steroid-related medical treatments. By maintaining strong relationships with global partners and continuously expanding its distribution networks, Zhejiang Xianju Pharmaceutical not only sustains its profitability but also plays a critical role in shaping healthcare outcomes around the world. The company's growth trajectory suggests a finely balanced strategy that combines innovation, production excellence, and market expansion.
See Also
What is Zhejiang Xianju Pharmaceutical Co Ltd's Net Income (Common)?
Net Income (Common)
621.7m
CNY
Based on the financial report for Sep 30, 2024, Zhejiang Xianju Pharmaceutical Co Ltd's Net Income (Common) amounts to 621.7m CNY.
What is Zhejiang Xianju Pharmaceutical Co Ltd's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
30%
Over the last year, the Net Income (Common) growth was -10%. The average annual Net Income (Common) growth rates for Zhejiang Xianju Pharmaceutical Co Ltd have been 1% over the past three years , 10% over the past five years , and 30% over the past ten years .
You don't have any saved screeners yet